F. Tas Et Al. , "Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients," TUMOR BIOLOGY , vol.35, no.4, pp.3327-3331, 2014
Tas, F. Et Al. 2014. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients. TUMOR BIOLOGY , vol.35, no.4 , 3327-3331.
Tas, F., Karabulut, S., Serilmez, M., Ciftci, R., & Duranyildiz, D., (2014). Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients. TUMOR BIOLOGY , vol.35, no.4, 3327-3331.
Tas, Faruk Et Al. "Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients," TUMOR BIOLOGY , vol.35, no.4, 3327-3331, 2014
Tas, Faruk Et Al. "Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients." TUMOR BIOLOGY , vol.35, no.4, pp.3327-3331, 2014
Tas, F. Et Al. (2014) . "Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients." TUMOR BIOLOGY , vol.35, no.4, pp.3327-3331.
@article{article, author={Faruk TAŞ Et Al. }, title={Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients}, journal={TUMOR BIOLOGY}, year=2014, pages={3327-3331} }